News
In this article, we will take a detailed look at the Top 10 Trending Stocks to Watch Ahead of Nvidia Earnings.
North Union notched a school record for goals scored in a girls soccer game as the Lady Cats defeated Pleasant 19-1 on Saturday at NU. Kale Keigley had five goals for North Union (3-0-1), tying a ...
CVS is opting against covering a twice-yearly injectable HIV prevention drug, drawing criticism from advocates who are ...
While Gilead Sciences posted a strong Q2 earnings print, GILD stock saw profit-taking. Here's why the red ink could be an ...
CVS Health, one of the nation’s largest pharmacy benefit managers, has declined to cover Gilead’s newly FDA-approved HIV ...
14h
Dealbreaker on MSNGilead Sciences Gains In Vivo Cell Therapy Capability With $350M Interius Bio Acquisition
Kite, the Santa Monica, California-based cell therapy subsidiary of Gilead, has entered a definitive agreement to pay $350 ...
Fort Worth’s oldest African American Baptist church, which was recently put on a list of Most Endangered Places in the city, ...
Here are the nominees for the Marion Star Football Player of Week 1 Poll that runs through early Tuesday morning.
The Handmaid's Tale is full of ostensibly harmless-sounding catchphrases whose entire meaning only reveals itself when read ...
It was a new season, but Jonathan Alder’s football squad made a big statement. The Pioneers started the year on the road at ...
Gilead's Kite unit has reached an agreement to buy Interius BioTherapeutics, boosting its in vivo cell therapy credentials.
Gilead Sciences has achieved success with its HIV treatment drugs, including tenofovir disoproxil fumarate, but faces criticism for pricing and access issues. Learn about the controversy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results